Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Mapping White Adipose Tissue lipid UPtake to cardiovascular disease initiation

Project description

Fat tissue dysfunction and cardiovascular disease

Obesity is a leading driver of cardiovascular disease. However, the precise mechanisms connecting fat tissue dysfunction to vascular damage remain poorly understood. As obesity rates rise globally, resolving these mechanisms is essential for developing new preventive and therapeutic strategies. The key objective of the ERC-funded WATs-UP project is to investigate how obesity-driven changes in white adipose tissue alter cholesterol and fatty acid metabolism. Using novel transgenic mouse models and human 3D adipocyte systems, researchers will test how changes in lipid metabolism lead to vascular dysfunction and atherosclerosis. Ultimately, the goal is to identify new therapeutic targets against metabolic and cardiovascular disease in obesity.

Objective

Obesity is associated with adipose tissue dysfunction and greatly increased risk for developing not only metabolic pathologies but also cardiovascular disease (CVD). While insulin resistance and adipose-derived cytokines are established drivers of vascular dysfunction and atherosclerosis initiation, the direct contribution of changes in white adipose tissue (WAT) lipid uptake on vascular health has remained unresolved, yet would open up novel treatment opportunities. My lab has built an arsenal of unique transgenic mouse models and organotypic human in vitro systems for mapping WAT lipid dynamics, yielding exciting preliminary data and the opportunity for us to now address this key question. In WATs-UP, we will untangle the mechanisms reducing WAT fatty acid uptake in obesity on a cellular, molecular and systemic level across humans and mice, and map the consequences for vascular function and atherosclerosis initiation. Specifically, we will harness insights from novel transgenic mouse lines developed by my lab to show how obesity-driven adipocyte enlargement alters WAT uptake of cholesterol and fatty acids; use our human 3D model of unilocular adipocytes to map how increased cholesterol uptake during obesity impairs adipocyte fatty acid metabolism; and transgenic mice to determine the relative contribution of triglyceridemia versus other WAT-derived cardiovascular risk factors for vascular lipid accumulation. Together, WATs-UP will significantly advance our molecular understanding of how weight gain fuels triglyceridemia and vascular dysfunction, opening novel therapeutic opportunities to combat both metabolic and CVD in obesity. With my combined expertise in metabolism and vascular biology, and the unique experimental in vivo and in vitro models developed by us, we are in a prime position to resolve the mechanisms controlling lipid dynamics of the obese WAT and their consequences for cardiovascular health, and identify novel preventive targets against them.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-COG

See all projects funded under this call

Host institution

KAROLINSKA INSTITUTET
Net EU contribution
€ 2 000 000,00
Address
NOBELS VAG 5
171 77 STOCKHOLM
Sweden
Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 2 000 000,00

Beneficiaries (1)